A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM
מצבים רפואיים
Glioblastoma Multiforme · Recurrent Glioblastoma
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
University of Alabama Birmingham, Birmingham, Alabama, United States
University of California San Diego, San Diego, California, United States
Contact: Principal Investigator (Zachary Berman, MD)University of California San Francisco, San Francisco, California, United States
Contact: Principal Investigator (Nicholas Butowski, MD)Mayo Jacksonville, Jacksonville, Florida, United States
Contact: Principal Investigator (Alfredo Quinones-Hinojosa, MD)Northwestern Univerity, Chicago, Illinois, United States
Contact: Principal Investigator (Samdeep Mouli, MD)Johns Hopkins Interventional Radiology Center, Baltimore, Maryland, United States
Washington University School of Medicine, St Louis, Missouri, United States
Contact: Principal Investigator (Arindam Chatterjee, M.D.)Lenox Hill Hospital, New York, New York, United States
Contact: Principal Investigator (John Boockvar, MD)MD Anderson Cancer Center, Houston, Texas, United States
Contact: Principal Investigator (Stephen Chen, MD)
מובילי המחקר
Riad Salem, M.D.
Principal Investigator
Northwestern University
Roger Stupp, M.D.
Principal Investigator
Northwestern University